@article{be41ff03ac954762a189547711d1b20d,
title = "Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia",
abstract = "The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.",
keywords = "CLSI, Enterobacteriaceae, bacteremia, cefepime, cefepime-susceptible dose-dependent, susceptibility",
author = "Foong, {Kap Sum} and Carlson, {Abigail L.} and Satish Munigala and Burnham, {Carey Ann D.} and Warren, {David K.}",
note = "Funding Information: Financial support. Research reported in this publication was supported in part by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UL1 TR002345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",
year = "2019",
month = aug,
day = "1",
doi = "10.1093/ofid/ofz341",
language = "English",
volume = "6",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
number = "8",
}